SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

FDC - Quaterly Results

06 Nov 2024 Evaluate
The September 2024 quarter revenue stood at Rs. 5051.04 millions, up 5.30% as compared to Rs. 4796.98 millions during the corresponding quarter last year.Profit for the quarter ended September 2024 grew by 2.68% to Rs. 739.73 millions from Rs. 720.41 millions.Operating Profit saw a handsome growth to 1070.78 millions from 1060.95 millions in the quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 5051.04 4796.98 5.30 11292.45 10097.38 11.84 19161.87 17770.32 7.83
Other Income 346.78 273.85 26.63 628.31 571.69 9.90 1032.16 539.12 91.45
PBIDT 1070.78 1060.95 0.93 2769.24 2558.85 8.22 4416.74 3084.87 43.17
Interest 10.71 10.51 1.90 23.63 20.89 13.12 40.00 40.39 -0.97
PBDT 1060.07 1050.44 0.92 2745.61 2537.96 8.18 4376.74 3044.48 43.76
Depreciation 137.58 98.13 40.20 247.53 194.01 27.59 397.29 387.58 2.51
PBT 922.49 952.31 -3.13 2498.08 2343.95 6.58 3979.45 2656.90 49.78
TAX 182.76 231.90 -21.19 608.46 538.03 13.09 907.82 647.25 40.26
Deferred Tax -17.24 16.71 -203.17 48.46 17.84 171.64 51.63 -42.75 -220.77
PAT 739.73 720.41 2.68 1889.62 1805.92 4.63 3071.63 2009.65 52.84
Equity 162.81 162.81 0.00 162.81 165.91 -1.87 162.81 165.91 -1.87
PBIDTM(%) 21.20 22.12 -4.15 24.52 25.34 -3.23 23.05 17.36 32.78

FDC Share Price

358.65 2.60 (0.73%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×